|
PEX12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.621850E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.037000E-03 |
| Normal-vs-Stage2 |
4.719200E-01 |
| Normal-vs-Stage3 |
2.380100E-03 |
| Normal-vs-Stage4 |
1.618590E-01 |
| Stage1-vs-Stage2 |
5.263600E-01 |
| Stage1-vs-Stage3 |
2.553200E-01 |
| Stage1-vs-Stage4 |
8.711400E-01 |
| Stage2-vs-Stage3 |
1.363790E-01 |
| Stage2-vs-Stage4 |
5.497200E-01 |
| Stage3-vs-Stage4 |
5.338000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.464600E-03 |
| Normal-vs-AfricanAmerican |
8.039100E-03 |
| Normal-vs-Asian |
5.420400E-01 |
| Caucasian-vs-AfricanAmerican |
5.259200E-01 |
| Caucasian-vs-Asian |
9.239800E-01 |
| AfricanAmerican-vs-Asian |
9.003600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.577600E-04 |
| Normal-vs-Female |
1.683170E-01 |
| Male-vs-Female |
3.532600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.655640E-03 |
| Normal-vs-Extreme_Weight |
6.001800E-04 |
| Normal-vs-Obese |
3.802100E-02 |
| Normal-vs-Extreme_Obese |
9.965000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.200600E-01 |
| Normal_Weight-vs-Obese |
3.056000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.420180E-01 |
| Extreme_Weight-vs-Obese |
4.115800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.726430E-01 |
| Obese-vs-Extreme_Obese |
3.845000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.581000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.696600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.64093999999171E-05 |
| Normal-vs-Age(81-100Yrs) |
2.449700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.253000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.787700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.818300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.004500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.831900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.307000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.230590E-01 |
| Normal-VS-Type2 PRCC |
2.0187999999921E-05 |
| Normal-VS-KIRP CIMP |
1.535050E-01 |
| Normal-VS-Unclassified PRCC |
9.430800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.759240E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.655600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.536000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.065400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.442400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.551800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.967900E-04 |
| Normal-vs-N1 |
4.752200E-04 |
| Normal-vs-N2 |
3.319400E-01 |
| N0-vs-N1 |
5.770600E-01 |
| N0-vs-N2 |
9.291400E-01 |
| N1-vs-N2 |
8.558400E-01 |
|
|
